{"title":"世界卫生组织烟草控制学习框架公约。","authors":"Joanna E Cohen, Matthew L Myers, Indu B Ahluwalia","doi":"10.1089/hs.2023.0094","DOIUrl":null,"url":null,"abstract":"We are pleased that the World Health Organization (WHO) is developing a pandemic treaty to improve the global response to future pandemics. In their article, De Luca and Ramirez rightly argue that a pandemic treaty should be informed by experiences with WHO’s existing treaty, the WHO Framework Convention on Tobacco Control (WHO FCTC), which came into force in 2005. However, the authors have mischaracterized the WHO FCTC and made criticisms that could hinder a productive discussion about a treaty for pandemics. The authors identify a limited emphasis on ‘‘harm reduction’’ as a key limitation of the WHO FCTC. However, the treaty itself includes ‘‘harm reduction strategies’’ in its definition of tobacco control. As the authors indicate, harm reduction encompasses actions ‘‘aimed at reducing the negative effects of health behaviors without necessarily extinguishing the problematic health behaviors completely or permanently.’’ The WHO FCTC and its guidelines for implementation—which include requiring smoke-free public places; banning tobacco advertising, promotion, and sponsorship; and reducing the attractiveness of tobacco products by limiting flavoring agents—allow the continuation of product use, while reducing the negative effects. Further, the treaty applies to all tobacco products, including products beyond cigarettes. The Conference of the Parties to the WHO FCTC, the governing body of the Convention, has outlined measures that Parties should prioritize to address the challenge of tobacco products, such as heated tobacco products, as well as policy objectives and options for Parties to consider in regulating electronic nicotine delivery systems and electronic non-nicotine delivery systems. It is also crucial to point out that the relationship between the tobacco industry and tobacco-caused death and disease is very different than the relationship of pharmaceutical and other companies to an infectious disease pandemic. The tobacco industry’s own products are responsible for the deaths and diseases the treaty addresses. This is not the case with a pandemic caused by an infectious agent. Tobacco companies are driven to sell their products and find new users, which is a fundamental and irreconcilable conflict","PeriodicalId":12955,"journal":{"name":"Health Security","volume":" ","pages":"428-429"},"PeriodicalIF":2.1000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541915/pdf/","citationCount":"0","resultStr":"{\"title\":\"WHO Framework Convention on Tobacco Control Learnings.\",\"authors\":\"Joanna E Cohen, Matthew L Myers, Indu B Ahluwalia\",\"doi\":\"10.1089/hs.2023.0094\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"We are pleased that the World Health Organization (WHO) is developing a pandemic treaty to improve the global response to future pandemics. In their article, De Luca and Ramirez rightly argue that a pandemic treaty should be informed by experiences with WHO’s existing treaty, the WHO Framework Convention on Tobacco Control (WHO FCTC), which came into force in 2005. However, the authors have mischaracterized the WHO FCTC and made criticisms that could hinder a productive discussion about a treaty for pandemics. The authors identify a limited emphasis on ‘‘harm reduction’’ as a key limitation of the WHO FCTC. However, the treaty itself includes ‘‘harm reduction strategies’’ in its definition of tobacco control. As the authors indicate, harm reduction encompasses actions ‘‘aimed at reducing the negative effects of health behaviors without necessarily extinguishing the problematic health behaviors completely or permanently.’’ The WHO FCTC and its guidelines for implementation—which include requiring smoke-free public places; banning tobacco advertising, promotion, and sponsorship; and reducing the attractiveness of tobacco products by limiting flavoring agents—allow the continuation of product use, while reducing the negative effects. Further, the treaty applies to all tobacco products, including products beyond cigarettes. The Conference of the Parties to the WHO FCTC, the governing body of the Convention, has outlined measures that Parties should prioritize to address the challenge of tobacco products, such as heated tobacco products, as well as policy objectives and options for Parties to consider in regulating electronic nicotine delivery systems and electronic non-nicotine delivery systems. It is also crucial to point out that the relationship between the tobacco industry and tobacco-caused death and disease is very different than the relationship of pharmaceutical and other companies to an infectious disease pandemic. The tobacco industry’s own products are responsible for the deaths and diseases the treaty addresses. This is not the case with a pandemic caused by an infectious agent. Tobacco companies are driven to sell their products and find new users, which is a fundamental and irreconcilable conflict\",\"PeriodicalId\":12955,\"journal\":{\"name\":\"Health Security\",\"volume\":\" \",\"pages\":\"428-429\"},\"PeriodicalIF\":2.1000,\"publicationDate\":\"2023-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541915/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Health Security\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1089/hs.2023.0094\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/8/8 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Health Security","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1089/hs.2023.0094","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/8/8 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
WHO Framework Convention on Tobacco Control Learnings.
We are pleased that the World Health Organization (WHO) is developing a pandemic treaty to improve the global response to future pandemics. In their article, De Luca and Ramirez rightly argue that a pandemic treaty should be informed by experiences with WHO’s existing treaty, the WHO Framework Convention on Tobacco Control (WHO FCTC), which came into force in 2005. However, the authors have mischaracterized the WHO FCTC and made criticisms that could hinder a productive discussion about a treaty for pandemics. The authors identify a limited emphasis on ‘‘harm reduction’’ as a key limitation of the WHO FCTC. However, the treaty itself includes ‘‘harm reduction strategies’’ in its definition of tobacco control. As the authors indicate, harm reduction encompasses actions ‘‘aimed at reducing the negative effects of health behaviors without necessarily extinguishing the problematic health behaviors completely or permanently.’’ The WHO FCTC and its guidelines for implementation—which include requiring smoke-free public places; banning tobacco advertising, promotion, and sponsorship; and reducing the attractiveness of tobacco products by limiting flavoring agents—allow the continuation of product use, while reducing the negative effects. Further, the treaty applies to all tobacco products, including products beyond cigarettes. The Conference of the Parties to the WHO FCTC, the governing body of the Convention, has outlined measures that Parties should prioritize to address the challenge of tobacco products, such as heated tobacco products, as well as policy objectives and options for Parties to consider in regulating electronic nicotine delivery systems and electronic non-nicotine delivery systems. It is also crucial to point out that the relationship between the tobacco industry and tobacco-caused death and disease is very different than the relationship of pharmaceutical and other companies to an infectious disease pandemic. The tobacco industry’s own products are responsible for the deaths and diseases the treaty addresses. This is not the case with a pandemic caused by an infectious agent. Tobacco companies are driven to sell their products and find new users, which is a fundamental and irreconcilable conflict
期刊介绍:
Health Security is a peer-reviewed journal providing research and essential guidance for the protection of people’s health before and after epidemics or disasters and for ensuring that communities are resilient to major challenges. The Journal explores the issues posed by disease outbreaks and epidemics; natural disasters; biological, chemical, and nuclear accidents or deliberate threats; foodborne outbreaks; and other health emergencies. It offers important insight into how to develop the systems needed to meet these challenges. Taking an interdisciplinary approach, Health Security covers research, innovations, methods, challenges, and ethical and legal dilemmas facing scientific, military, and health organizations. The Journal is a key resource for practitioners in these fields, policymakers, scientific experts, and government officials.